Bland-Altman plot indicating the agreement between the optic nerve sheath diameter measured with CT scan and US. by Marco Carbonara (11483575)

Subjects:

Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection. by Ryan J. Treves (13527735)

Mean concentrations of sum monoterpenes and single monoterpenes: α-pinene, β-pinene, myrcene, limonene, β-(E)-ocimene, and α-terpineol obtained from the 10 distillation time (DT) f... by Valtcho D. Zheljazkov (627617)

Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …”

Description of variables in the mean technical efficiency function. by James Anaba Akolgo (14129379)

Subjects:

Characteristics of HACE respondents by year. by David Henderson (4612354)

Subjects:

SD and mean TTC under different weights. by Jianrong Cai (14245136)

Subjects:

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... by figshare admin karger (2628495)

Microscopic view of <i>spirulina</i> spp. by Maha Rehman (17114332)

Subjects:

Supplementary data file of graphs. by Maha Rehman (17114332)

Subjects:

Overall and domain-specific mean readiness score by survey years, 2014 and 2017. by Rajon Banik (12066099)

Subjects:

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects: